Changes in Histidine Decarboxylase, Histamine N-Methyltransferase and Histamine Receptors in Neuropsychiatric Disorders.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Handbook of Experimental Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/164_2016_125PMID 28233178
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structural Analysis of the Histamine H1 Receptor.

  2017cited by this paper
• Leucine 208 in human histamine N-methyltransferase emerges as a hotspot for protein stability rationalizing the role of the L208P variant in intellectual disability.

  2017cited by this paper
• Histidine Decarboxylase Knockout Mice as a Model of the Pathophysiology of Tourette Syndrome and Related Conditions.

  2017cited by this paper
• Behavioural phenotype of histamine H4 receptor knockout mice: Focus on central neuronal functions

  2017cited by this paper
• Role of the Histamine H3 Receptor in the Central Nervous System.

  2016cited by this paper
• Role of the Histamine H4-Receptor in Bronchial Asthma.

  2016cited by this paper
• The histamine H4-receptor and the central and peripheral nervous system: A critical analysis of the literature.

  2016cited by this paper
• Histamine H2 Receptor in Blood Cells: A Suitable Target for the Treatment of Acute Myeloid Leukemia.

  2016cited by this paper
• Thr105Ile (rs11558538) polymorphism in the histamine N-methyltransferase (HNMT) gene and risk for Parkinson disease

  2016cited by this paper
• The human histaminergic system in neuropsychiatric disorders.

  2015cited by this paper
• International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors

  2015cited by this paper
• Association of Histamine N-Methyltransferase Thr105Ile Polymorphism with Parkinson’s Disease and Schizophrenia in Han Chinese: A Case-Control Study

  2015cited by this paper
• Interactions of the histamine and hypocretin systems in CNS disorders

  2015cited by this paper
• Schizophrenia-Like Symptoms in Narcolepsy Type 1: Shared and Distinctive Clinical Characteristics

  2015cited by this paper
• Mutations in the histamine N-methyltransferase gene, HNMT, are associated with nonsyndromic autosomal recessive intellectual disability.

  2015cited by this paper
• Histamine H3 Receptor Antagonists for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials

  2015cited by this paper
• A Phase II study of a histamine H₃ receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy.

  2015cited by this paper
• Modulation of behavior by the histaminergic system: lessons from HDC-, H3R- and H4R-deficient mice.

  2014cited by this paper
• Impaired Fear Extinction as Displayed by Serotonin Transporter Knockout Rats Housed in Open Cages Is Disrupted by IVC Cage Housing

  2014cited by this paper
• A search for functional histamine H4 receptors in the human, guinea pig and mouse brain

  2014cited by this paper
• Dual Cases of Type 1 Narcolepsy with Schizophrenia and Other Psychotic Disorders

  2014cited by this paper
• Histidine decarboxylase deficiency causes tourette syndrome: parallel findings in humans and mice.

  2014cited by this paper
• A randomized trial of the efficacy and safety of the H3 antagonist ABT-288 in cognitive impairment associated with schizophrenia.

  2014cited by this paper
• Circadian Factor BMAL1 in Histaminergic Neurons Regulates Sleep Architecture

  2014cited by this paper
• Comorbidity of narcolepsy and schizophrenia in an adolescent patient.

  2014cited by this paper
• Modulation of behavior by the histaminergic system: lessons from H(1)R-and H(2)R-deficient mice.

  2014cited by this paper
• Conditional Ablation of Orexin/Hypocretin Neurons: A New Mouse Model for the Study of Narcolepsy and Orexin System Function

  2014cited by this paper
• Efficacy and Tolerability of Histamine-2 Receptor Antagonist Adjunction of Antipsychotic Treatment in Schizophrenia: A Meta-analysis of Randomized Placebo-controlled Trials

  2014cited by this paper
• A randomized, double-blind, placebo-controlled, 16-week study of the H3 receptor antagonist, GSK239512 as a monotherapy in subjects with mild-to-moderate Alzheimer's disease.

  2014cited by this paper
• The histaminergic network in the brain: basic organization and role in disease

  2013cited by this paper
• Greatly increased numbers of histamine cells in human narcolepsy with cataplexy

  2013cited by this paper
• Expression of histamine receptor genes Hrh3 and Hrh4 in rat brain endothelial cells

  2013cited by this paper
• Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial.

  2013cited by this paper
• Pleiotropic effect of histamine H4 receptor modulation in the central nervous system.

  2013cited by this paper
• Randomized crossover study of the histamine H3 inverse agonist MK-0249 for the treatment of cognitive impairment in patients with schizophrenia.

  2013cited by this paper
• A Randomized Clinical Trial of Histamine 2 Receptor Antagonism in Treatment-Resistant Schizophrenia

  2013cited by this paper
• Increase of histaminergic tuberomammillary neurons in narcolepsy

  2013cited by this paper
• Unaltered histaminergic system in depression: a postmortem study.

  2013cited by this paper
• Neuronal histaminergic system in aging and age-related neurodegenerative disorders.

  2013cited by this paper
• Review of the histamine system and the clinical effects of H1 antagonists: basis for a new model for understanding the effects of insomnia medications.

  2013cited by this paper
• Neuronal histamine production remains unaltered in Parkinson's disease despite the accumulation of Lewy bodies and Lewy neurites in the tuberomamillary nucleus.

  2012cited by this paper
• Diurnal fluctuation in histidine decarboxylase expression, the rate limiting enzyme for histamine production, and its disorder in neurodegenerative diseases.

  2012cited by this paper
• Histamine N-methyltransferase Thr105Ile polymorphism is associated with Parkinson's disease.

  2012cited by this paper
• Alterations in the histaminergic system in Alzheimer's disease: a postmortem study.

  2012cited by this paper
• Pilot randomized controlled study of a histamine receptor inverse agonist in the symptomatic treatment of AD.

  2012cited by this paper
• Alterations in the histaminergic system in the substantia nigra and striatum of Parkinson's patients: a postmortem study.

  2012cited by this paper
• The serotonin transporter gene and functional and pathological adaptation to environmental variation across the life span.

  2012cited by this paper
• Pitolisant, an Inverse Agonist of the Histamine H3 Receptor: An Alternative Stimulant for Narcolepsy-Cataplexy in Teenagers With Refractory Sleepiness

  2012cited by this paper
• Commercially available antibodies against human and murine histamine H4-receptor lack specificity

  2011cited by this paper
• Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years.

  2011cited by this paper
• Narcolepsy presenting as schizophrenia: a literature review and two case reports.

  2011cited by this paper
• Histamine receptors in the CNS as targets for therapeutic intervention.

  2011cited by this paper
• Discovery of Histamine H3 Antagonists for the Treatment of Cognitive Disorders and Alzheimer's Disease

  2011cited by this paper
• Functional Increase of Brain Histaminergic Signaling in Huntington's Disease

  2011cited by this paper
• Hallucinations in narcolepsy with and without cataplexy: contrasts with Parkinson's disease.

  2011cited by this paper
• L-histidine decarboxylase and Tourette's syndrome.

  2010cited by this paper
• A quantitative in situ hybridization protocol for formalin-fixed paraffin-embedded archival post-mortem human brain tissue.

  2010cited by this paper
• CSF Levels of the Histamine Metabolite tele-Methylhistamine are only Slightly Decreased in Alzheimer's Disease

  2010cited by this paper
• Regional Differential Effects of the Novel Histamine H3 Receptor Antagonist 6-[(3-Cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-N-methyl-3-pyridinecarboxamide hydrochloride (GSK189254) on Histamine Release in the Central Nervous System of Freely Moving Rats

  2010cited by this paper
• JNJ-10181457, a selective non-imidazole histamine H(3) receptor antagonist, normalizes acetylcholine neurotransmission and has efficacy in translational rat models of cognition.

  2009cited by this paper
• A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: the empirical basis for U.S. clinical practice.

  2009cited by this paper
• Histamine, antihistamines, and the central nervous system.

  2009cited by this paper
• Psychotic symptoms in narcolepsy: phenomenology and a comparison with schizophrenia.

  2009cited by this paper
• The histamine H4 receptor is functionally expressed on neurons in the mammalian CNS

  2009cited by this paper
• The Nonsynonymous Thr105Ile Polymorphism of the Histamine N-Methyltransferase is Associated to the Risk of Developing Essential Tremor

  2008cited by this paper
• The histamine N-methyltransferase T105I polymorphism affects active site structure and dynamics.

  2008cited by this paper
• Histamine in the nervous system.

  2008cited by this paper
• An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients.

  2008cited by this paper
• The physiological and pathophysiological roles of neuronal histamine: an insight from human positron emission tomography studies.

  2007cited by this paper
• Nonsynonymous Polymorphisms of Histamine-Metabolising Enzymes in Patients with Parkinson’s Disease

  2007cited by this paper
• Involvement of brain endogenous histamine in the degeneration of dopaminergic neurons in 6-hydroxydopamine-lesioned rats.

  2007cited by this paper
• GSK189254, a Novel H3 Receptor Antagonist That Binds to Histamine H3 Receptors in Alzheimer's Disease Brain and Improves Cognitive Performance in Preclinical Models

  2007cited by this paper
• Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia.

  2007cited by this paper
• Deep brain stimulation for treatment-resistant depression.

  2005cited by this paper
• Decreased histamine H1 receptor binding in the brain of depressed patients

  2004cited by this paper
• The role of histamine and the tuberomamillary nucleus in the nervous system

  2003cited by this paper
• Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene

  2003cited by this paper
• Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy

  2002cited by this paper
• Theoretical 3D model of histamine N-methyltransferase: insights into the effects of a genetic polymorphism on enzymatic activity and thermal stability.

  2001cited by this paper
• Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity.

  2001cited by this paper
• Two polymorphic forms of human histamine methyltransferase: structural, thermal, and kinetic comparisons.

  2001cited by this paper
• Narcolepsy:Clinical Features, New Pathophysiologic Insights, and Future Perspectives

  2001cited by this paper
• Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response.

  2000cited by this paper
• Histamine Infusion Induces a Selective Dopaminergic Neuronal Death Along with an Inflammatory Reaction in Rat Substantia Nigra

  2000cited by this paper
• An altered histaminergic innervation of the substantia nigra in Parkinson's disease.

  2000cited by this paper
• Familial aggregation of psychotic symptoms in Huntington's disease.

  2000cited by this paper
• Histamine H2 receptor gene variants: lack of association with schizophrenia

  2000cited by this paper
• A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains

  2000cited by this paper
• Brain structures and mechanisms involved in the control of cortical activation and wakefulness, with emphasis on the posterior hypothalamus and histaminergic neurons.

  2000cited by this paper
• Histamine H(1) receptors in patients with Alzheimer's disease assessed by positron emission tomography.

  2000cited by this paper
• Reduced Number of Hypocretin Clinical Study Neurons in Human Narcolepsy

  2000cited by this paper
• Sex differences in the distribution of androgen receptors in the human hypothalamus

  2000cited by this paper
• Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation.

  1999cited by this paper
• Human histamine N-methyltransferase pharmacogenetics: common genetic polymorphisms that alter activity.

  1998cited by this paper
• Familial aggregation of schizophrenia-like symptoms in Huntington's disease.

  1998cited by this paper
• Clinical neurochemistry: developments in dementia research based on brain bank material

  1998cited by this paper
• Sleep-onset rapid eye movement periods in neuropsychiatric disorders: implications for the pathophysiology of psychosis.

  1997cited by this paper
• Individuals with schizophrenia have an increased incidence of the H2R649G allele for the histamine H2 receptor gene.

  1996cited by this paper
• Large neurons in the tuberomammillary nucleus in patients with Parkinson's disease and multiple system atrophy

  1996cited by this paper
• An open-label study of the therapeutic efficacy of high-dose famotidine adjuvant pharmacotherapy in schizophrenia: preliminary evidence for treatment efficacy.

  1996cited by this paper

• Altered levels of sphingomyelins, ceramides, glycerophospholipids, and diacylglycerols in thymoma tissues.

  2025cites this paper
• Elevated Serum Histamine N‐Methyltransferase Levels Are Associated With the Pathophysiology of Major Depressive Disorder: A Case–Control Study

  2025cites this paper
• Assessment of the Relationship Between Amino Acid Status and Parkinson's Disease: A Comprehensive Review and Meta-analysis.

  2024cites this paper
• Importance of solvents role in molecular and electronic properties, DFT, spectroscopic, Electron-hole transition, chemical reactivity, topology and molecular docking investigations of (±)-2-(2-{4-[(4-chlorophenyl)-phenylmethyl] piperazin-1-yl} ethoxy)ethanol

  2023cites this paper
• Drug Repurposing to Inhibit Histamine N-Methyl Transferase

  2023cites this paper
• HNMT Upregulation Induces Cancer Stem Cell Formation and Confers Protection against Oxidative Stress through Interaction with HER2 in Non-Small-Cell Lung Cancer

  2022cites this paper
• Decarboxylases as hypothetical targets for actions of organophosphates: Molecular modeling for prediction of hidden and unexpected health threats.

  2022cites this paper
• PEA-OXA ameliorates allodynia, neuropsychiatric and adipose tissue remodeling induced by social isolation.

  2022cites this paper
• The prefrontal cortex shows widespread decrease in H3 histamine receptor binding densities in rats with genetic generalized epilepsies.

  2022cites this paper
• Histamine H3 and H4 receptors modulate Parkinson's disease induced brain pathology. Neuroprotective effects of nanowired BF-2649 and clobenpropit with anti-histamine-antibody therapy.

  2021cites this paper
• Histamine: A Key Neuromodulator of Memory Consolidation and Retrieval.

  2021cites this paper
• Changes in Histaminergic System in Neuropsychiatric Disorders and the Potential Treatment Consequences

  2021cites this paper
• Inhibition of Astrocytic Histamine N-Methyltransferase as a Possible Target for the Treatment of Alzheimer’s Disease

  2021cites this paper
• Investigating Causality Between Blood Metabolites and Emotional and Behavioral Responses to Traumatic Stress: a Mendelian Randomization Study

  2019cites this paper
• Novel Biochemical Insights in the Cerebrospinal Fluid of Patients with Neurosyphilis Based on a Metabonomics Study

  2019cites this paper
• Metabolome-Wide Mendelian Randomization Analysis of Emotional and Behavioral Responses to Traumatic Stress

  2019cites this paper
• Brain histamine modulates recognition memory: possible implications in major cognitive disorders

  2018cites this paper
• Heterómeros de receptores de dopamina d1 y de histamina h3 como potenciales dianas terapéuticas en trastornos adictivos y enfermedades neurodegenerativas

  2018cites this paper
• Acute anxiety disorder, major depressive disorder, bipolar disorder and schizophrenia are related to different patterns of nigrostriatal and mesolimbic dopamine dysfunction

  2018cites this paper